Recruitment for Faculty posts at College of Pharmacy, Solapur University
Solapur University was established on 1st August 2004 and was inaugurated on 03-08-2004 by the Governor of Maharashtra. The formation of the university at Solapur was a long cherished desire of the people of this region. Earlier, to the formation of University, Solapur had a P.G. Centre of Shivaji University for over two decades. The centre for P.G. studies had three postgraduate science departments and 7 postgraduate courses conducted in the P.G. departments. With this sound background Solapur University has been established to cater the needs of over 60,000 students community. The university is poised for an ambitious growth. The University is now a hub of various academic activities. Good number of Engineering, Agricultural, Architectural, Medical and Traditional institutions of national fame are located in and around the city. Solapur is a home of religious saints of various languages as the district is at a triple junction of linguistic states of Andhra, Karnataka and Maharashtra.
Applications are invited from eligible candidates for the following permanent non-grantable posts.
Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Each day, our employees around the world work together for patients – it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through our R&D organization, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.
This is a question we’ve asked ourselves over and over. It’s how we at Medtronic have made hearts beat stronger and longer. It’s how we’ve pushed the limits of what technology can do in and for the body. It’s how we will continue to alleviate pain, restore health and extend life. Rising costs, an aging population, and the burden of chronic disease impact us all. And no single entity in the healthcare system can solve these challenges alone. That’s why we’re stepping forward. That’s why we’re prepared to put the full power of our technologies, services, resources — and our people — to work with new partners, in new ways, to usher in a new era in healthcare.
Covance, a $15 billion Fortune 500 company, with operations in over 97 countries, has led the way in improving patient outcomes through visionary data sciences over the last five decades. We have supported 100% of the top 50 drugs in the market and all the oncology medicines approved in 2016. Our team of over 57,000 across the globe is committed to advancing healthcare and bringing new medicines to market sooner. Our unique perspectives, built from decades of scientific expertise and precision delivery, help our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Driven by a passion for excellence and a relentless commitment to quality, we unlock opportunities that advance innovation and deliver the promise of a healthier world. Together, with our large pharmaceutical and emerging biotech clients, Covance transforms today's health care challenges into tomorrow's solutions.
Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967. The Company operates both its Pharmaceuticals and Chemicals businesses in the country.
.png)
